Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe Cases
Beta-adrenoceptor Activation Reduces Host Viral Resistance by Preventing IFN-γ Production in Liver NK Cells
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
Cognitive Decline and Alzheimer’s Linked to Low Systemic REST Levels and Deficient Stress Protection of the Aging Brain
Microglia and TREM2 Microglia-Specific Gene May Exert a Protective Role in Alzheimer´s DiseaseMay 24, 2016
New Evidence Suggests Targeting Neuroinflammation May Be One Key to Slowing Alzheimer’s DiseaseAugust 16, 2016
Aducanumab Shows Promise and Impressive Effects in Reducing Alzheimer’s Amyloid-β PlaquesOctober 5, 2016
The Cross-talk between the Dopaminergic System and Innate Immunity: An Evolving ConceptMarch 27, 2018
New Evidence Linking Clusterin and Other Complement Proteins to Alzheimer’s Progression and PredictionSeptember 15, 2016
Antibiotics through Effects on the Microbiota-Gut-Brain Axis and Inflammatory Monocytes May Reshape Brain Hippocampal NeurogenesisApril 18, 2017
